Zygomycosis

Seminars in Respiratory and Critical Care Medicine

Volumn 25, Issue 2, 2004, Pages 221-231

  Freifeld, Alison G ^a   Iwen, Peter C ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Fungal infection; Immunocompromised host; Mucor; Zygomycosis

Indexed keywords

ABSIDIA; ANTIFUNGAL ACTIVITY; APOPHYSOMYCES ELEGANS; CLINICAL FEATURE; CRANIAL SINUS; CUNNINGHAMELLA; FUNGUS HYPHAE; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; MORTALITY; MUCORMYCOSIS; MYCOSIS; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REVIEW; RHIZOMUCOR; RHIZOPUS; SURGICAL TECHNIQUE; ZYGOMYCETES;

EID: 2142758691     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-824905     Document Type: Review

References (97)

1. Lee FY, Mossad SB, Adal KA. Pulmonary mucormycosis: the last 30 years. Arch Intern Med 1999;159:1301-1309
2. Kwon-Chung KJ, Bennett JE. Mucormycosis. In: Cann C, ed. Medical Mycology. Philadelphia: Lea & Febiger; 1992:524-559
3. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000;13:236-301
4. Sugar A. Agents of mucormycosis and related species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Vol 2. 5th ed. Philadelphia: Churchill Livingstone; 2000:2685-2694
5. Belin L. Sawmill alveolitis in Sweden. Int Arch Allergy Appl Immunol 1987;82:440-443
6. Wimander K, Belin L. Recognition of allergic alveolitis in the trimming department of a Swedish sawmill. Eur J Respir Dis Suppl 1980;107:163-167
7. Waldorf AR. Pulmonary defense mechanisms against opportunistic fungal pathogens. Immunol Ser 1989;47:243-271
8. Diamond RD, Clark RA. Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro. Infect Immun 1982;38:487-495
9. Waldorf AR, Ruderman N, Diamond RD. Specific susceptibility of mucormycosis in murine diabetes and broncholaveolar macrophage defense against Rhizopus. J Clin Invest 1984;74:150-160
10. Artis WM, Fountain JA, Delcher HK, Jones HE. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes 1982;31:1109-1114
11. Bagdade JD. Phagocytic and microbicidal function in diabetes mellitus. Acta Endocrinol Suppl (Copenh) 1976;205:27-34
12. Meyer RD, Rosen P, Armstrong D. Phycomycosis complicating leukemia and lymphoma. Ann Intern Med 1972;77:871-879
13. Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 2000;30:851-856
14. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002;34:909-917
15. Windus DW, Stokes TJ, Julian BA, Fenves AZ. Fatal Rhizopus infections in hemodialysis patients receiving deferoxamine. Ann Intern Med 1987;107:678-680
16. Daly AL, Velazquez LA, Bradley SF, Kauffman CA. Mucormycosis: association with deferoxamine therapy. Am J Med 1989;87:468-471
17. Eiser AR, Slifkin RF, Neff MS. Intestinal mucormycosis in hemodialysis patients following deferoxamine. Am J Kidney Dis 1987;10:71-73
18. Singh N, Gayowski T, Singh J, Yu VL. Invasive gastrointestinal zygomycosis in a liver transplant recipient: case report and review of zygomycosis in solid-organ transplant recipients. Clin Infect Dis 1995;20:617-620
19. Paparello SF, Parry RL, MacGillivray DC, Brock N, Mayers DL. Hospital-acquired wound mucormycosis. Clin Infect Dis 1992;14:350-352
20. Song WK, Park HJ, Cinn YW, et al. Primary cutaneous mucormycosis in a trauma patient. J Dermatol 1999;26:825-828
21. Sharma RR, Pawar SJ, Delmendo A, Lad SD, Athale SD. Fatal rhino-orbito-cerebral mucormycosis in an apparently normal host: case report and literature review. J Clin Neurosci 2001;8:583-586
22. Mitchell SJ, Gray J, Morgan ME, Hocking MD, Durbin GM. Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors. Lancet 1996;348:441-443
23. Oh D, Notrica D. Primary cutaneous mucormycosis in infants and neonates: case report and review of the literature. J Pediatr Surg 2002;37:1607-1611
24. Hejny C, Kerrison JB, Newman NJ, Stone CM. Rhino-orbital mucormycosis in a patient with acquired immunodeficiency syndrome (AIDS) and neutropenia. Am J Ophthalmol 2001;132:111-112
25. Sanchez MR, Ponge-Wilson I, Moy JA, Rosenthal S. Zygomycosis and HIV infection. J Am Acad Dermatol 1994;30(5 pt 2):904-908
26. Gonzalez CE, Rinaldi MG, Sugar AM. Zygomycosis. Infect Dis Clin North Am 2002;16:895-914
27. Rangel-Guerra RA, Martinez HR, Saenz C, Bosques-Padilla F, Estrada-Bellmann I. Rhinocerebral and systemic mucormycosis: clinical experience with 36 cases. J Neurol Sci 1996;143:19-30
28. Pagano L, Ricci P, Tonso A, et al. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto). Br J Haematol 1997;99:331-336
29. Gaziev D, Baronciani D, Galimberti M, et al. Mucormycosis after bone marrow transplantation: report of four cases in thalassemia and review of the literature. Bone Marrow Transplant 1996;17:409-414
30. Ferguson BJ. Mucormycosis of the nose and paranasal sinuses. Otolaryngol Clin North Am 2000;33:349-365
31. Sohail MA, Al Khabori M, Hyder J, Verma A. Acute fulminant fungal sinusitis: clinical presentation, radiological findings and treatment. Acta Trop 2001;80:177-185
32. Kyrmizakis DE, Doxas PG, Hajiioannou JK, Papadakis CE. Palate ulcer due to mucormycosis. J Laryngol Otol 2002;116:146-147
33. Blitzer A, Lawson W, Meyers BR, Biller HF. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope 1980;90:635-648
34. Tedder M, Spratt JA, Anstadt MP, et al. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg 1994;57:1044-1050
35. Latif S, Saffarian N, Bellovich K, Provenzano R. Pulmonary mucormycosis in diabetic renal allograft recipients. Am J Kidney Dis 1997;29:461-464
36. Demirag A, Elkhammas EA, Henry ML, et al. Pulmonary Rhizopus infection in a diabetic renal transplant recipient. Clin Transplant 2000;14:8-10
37. Veliath AJ, Rao R, Prabhu MR, Aurora AL. Cutaneous phycomycosis (mucormycosis) with fatal pulmonary dissemination. Arch Dermatol 1976;112:509-512
38. Bigby TD, Serota ML, Tierney LM Jr, Matthay MA. Clinical spectrum of pulmonary mucormycosis. Chest 1986;89:435-439
39. Pagano L, Ricci P, Nosari A, et al. Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukaemia in haematological complete remission. A retrospective study and review of the literature. Gimema Infection Program (Gruppo Italiano Malattie Ematologiche dell'Adulto). Br J Haematol 1995;89:500-505
40. Husari AW, Jensen WA, Kirsch CM, et al. Pulmonary mucormycosis presenting as an endobronchial lesion. Chest 1994;106:1889-1891
41. Everett ED, Pearson S, Rogers W. Rhizopus surgical wound infection with elasticized adhesive tape dressings. Arch Surg 1979;114:738-739
42. Adam RD, Hunter G, DiTomasso J, Comerci G Jr. Mucormycosis: emerging prominence of cutaneous infections. Clin Infect Dis 1994;19:67-76
43. Alsuwaida K. Primary cutaneous mucormycosis complicating the use of adhesive tape to secure the endotracheal tube. Can J Anaesth 2002;49:880-882
44. Bearer EA, Nelson PR, Chowers MY, Davis CE. Cutaneous zygomycosis caused by Saksenaea vasiformis in a diabetic patient. J Clin Microbiol 1994;32:1823-1824
45. Scalise A, Barchiesi F, Viviani MA, et al. Infection due to Absidia corymbifera in a patient with a massive crush trauma of the foot. J Infect 1999;38:191-192
46. Nomura J, Ruskin J, Sahebi F, Kogut N, Falk PM. Mucormycosis of the vulva following bone marrow transplantation. Bone Marrow Transplant 1997;19:859-860
47. Newton WD, Cramer FS, Norwood SH. Necrotizing fasciitis from invasive Phycomycetes. Crit Care Med 1987;15:331-332
48. Lakshmi V, Rani TS, Sharma S, et al. Zygomycotic necrotizing fasciitis caused by Apophysomyces elegans. J Clin Microbiol 1993;31:1368-1369
49. Mooney JE, Wanger A. Mucormycosis of the gastrointestinal tract in children: report of a case and review of the literature. Pediatr Infect Dis J 1993;12:872-876
50. Carr EJ, Scott P, Gradon JD. Fatal gastrointestinal mucormycosis that invaded the postoperative abdominal wall wound in an immunocompetent host. Clin Infect Dis 1999;29:956-957
51. Vadeboncoeur C, Walton JM, Raisen J, et al. Gastrointestinal mucormycosis causing an acute abdomen in the immuno-compromised pediatric patient: three cases. J Pediatr Surg 1994;29:1248-1249
52. Knoop C, Antoine M, Vachiery JL, et al. Gastric perforation due to mucormycosis after heart-lung and heart transplantation. Transplantation 1998;66:932-935
53. Jackman JD Jr, Simonsen RL. The clinical manifestations of cardiac mucormycosis. Chest 1992;101:1733-1736
54. Virmani R, Connor DH, McAllister HA. Cardiac mucormycosis: a report of five patients and review of 14 previously reported cases. Am J Clin Pathol 1982;78:42-47
55. Fong KM, Seneviratne EM, McCormack JG. Mucor cerebral abscess associated with intravenous drug abuse. Aust N Z J Med 1990;20:74-77
56. Cook BA, White CB, Blaney SM, Bass JW. Survival after isolated cerebral mucormycosis. Am J Pediatr Hematol Oncol 1989;11:330-333
57. Santos J, Espigado P, Romero C, et al. Isolated renal mucormycosis in two AIDS patients. Eur J Clin Microbiol Infect Dis 1994;13:430-432
58. Eucker J, Sezer O, Graf B, Possinger K. Mucormycoses. Mycoses 2001;44:253-260
59. Murphy RA, Miller WT Jr. Pulmonary mucormycosis. Semin Roentgenol 1996;31:83-87
60. Glazer M, Nusair S, Breuer R, et al. The role of BAL in the diagnosis of pulmonary mucormycosis. Chest 2000;117:279-282
61. Al-Abbadi MA, Russo K, Wilkinson EJ. Pulmonary mucormycosis diagnosed by bronchoalveolar lavage: a case report and review of the literature. Pediatr Pulmonol 1997;23:222-225
62. Chandler FW, Watts JC. Zygomycosis. In: Chandler FW, Watts JC, eds. Pathologic Diagnosis of Fungal Infections. Vol 1. Chicago: American Society of Clinical Pathologists; 1987:85-96
63. Ribes JA, Vanover-Sams C, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000;13:236-301
64. Yeo SF, Wong B. Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev 2002;15:465-484
65. Parfrey NA. Improved diagnosis and prognosis of mucormycosis: a dinicopathologic study of 33 cases. Medicine (Baltimore) 1986;65:113-123
66. Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol 1994;39:3-22
67. Schmidt JM, Poublon RM. Rhinocerebral mycosis in immunocompromised patients: a case report and review of the literature. Rhinology 1998;36:90-93
68. Otcenasek M, Buchta V. In vitro susceptibility to 9 antifungal agents of 14 strains of Zygomycetes isolated from clinical specimens. Mycopathologia 1994;128:135-137
69. Dannaoui E, Mouton JW, Meis JF, Verweij PE. Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosis. Antimicrob Agents Chemother 2002;46:1953-1959
70. Gomez-Lopez A, Cuenca-Estrella M, Monzon A, Rodriguez-Tudela JL. In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole. J Antimicrob Chemother 2001;48:919-921
71. Larkin JA, Montero JA. Efficacy and safety of amphotericin B lipid complex for zygomycosis. Infect Med 2003;20:201-206
72. Wali YA, al Lamki Z, al Kindi H, et al. Case report: successful outcome of invasive nasal sinus zygomycosis in a child with relapsed acute lymphoblastic leukaemia due to liposomal amphotericin B. Mycoses 2001;44:195-199
73. Dannaoui E, Afeltra J, Meis JF, Verweij PE. In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents. Antimicrob Agents Chemother 2002;46:2708-2711
74. Walsh TJ, Hiemenz JW, Seibel NL, et al. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis 1998;26:1383-1396
75. Linden P, Lee L, Walsh TJ. Retrospective analysis of the dosage of amphotericin B lipid complex for the treatment of invasive fungal infections. Pharmacotherapy 1999;19:1261-1268
76. Ng TT, Denning DW. Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections: evaluation of United Kingdom compassionate use data. Arch Intern Med 1995;155:1093-1098
77. Gebhard F, Chastagner P, Maillot D, et al. Favorable outcome of orbital nasal sinus mucormycosis complicating the induction treatment of acute lymphoblastic leukemia [in French]. Arch Pediatr 1995;2:47-51
78. Parkyn T, McNinch AW, Riordan T, Mott M. Zygomycosis in relapsed acute leukaemia. J Infect 2000;41:265-268
79. Gaviria JM, Grohskopf LA, Barnes R, Root RK. Successful treatment of rhinocerebral zygomycosis: a combined-strategy approach. Clin Infect Dis 1999;28:160-161
80. Kfoury AG, Smith JC, Farhoud HH, et al. Adjuvant intrapleural amphotericin B therapy for pulmonary mucormycosis in a cardiac allograft recipient. Clin Transplant 1997;11:608-612
81. Sun QN, Fothergill AW, McCarthy DI, Rinaldi MG, Graybill JR. In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes. Antimicrob Agents Chemother 2002;46:1581-1582
82. Sun QN, Najvar LK, Bocanegra R, Loebenberg D, Graybill JR. In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model. Antimicrob Agents Chemother 2002;46:2310-2312
83. Tobon AM, Arango M, Fernandez D, Restrepo A. Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy. Clin Infect Dis 2003;36:1488-1491
84. Greenberg N, Anstead G, Herbrecht R, et al. Posaconazole (POS) experience in the treatment of zygomycosis. Program and abstracts of the 43rd Annual ICAAC. Chicago, Illinois; September 14-17, 2003
85. Mazade MA, Margolin JF, Rossmann SN, Edwards MS. Survival from pulmonary infection with Cunninghamella bertholletiae: case report and review of the literature. Pediatr Infect Dis J 1998;17:835-839
86. McAdams HP, Rosado de Christenson M, Strollo DC, Patz EF Jr. Pulmonary mucormycosis: radiologic findings in 32 cases. AJR Am J Roentgenol 1997;168:1541-1548
87. Asai K, Suzuki K, Takahashi T, et al. Pulmonary resection with chest wall removal and reconstruction for invasive pulmonary mucormycosis during antileukemia chemotherapy. Jpn J Thorac Cardiovasc Surg 2003;51:163-166
88. Slavin MA, Kannan K, Buchanan MR, Sasadeusz J, Roberts AW. Successful allogeneic stem cell transplant after invasive pulmonary zygomycosis. Leuk Lymphoma 2002;43:437-439
89. Price JC, Stevens DL. Hyperbaric oxygen in the treatment of rhinocerebral mucormycosis. Laryngoscope 1980;90(5 pt 1): 737-747
90. Bentur Y, Shupak A, Ramon Y, et al. Hyperbaric oxygen therapy for cutaneous/soft-tissue zygomycosis complicating diabetes mellitus. Plast Reconstr Surg 1998;102:822-824
91. Ferguson BJ, Mitchell TG, Moon R, Camporesi EM, Farmer J. Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis. Rev Infect Dis 1988;10:551-559
92. Liles WC, Huang JE, van Burik JA, Bowden RA, Dale DC. Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens. J Infect Dis 1997;175:1012-1015
93. Brummer E, Maqbool A, Stevens DA. Protection of bronchoalveolar macrophages by granulocyte-macrophage colony-stimulating factor against dexamethasone suppression of fungicidal activity for Aspergillus fumigatus conidia. Med Mycol 2001;39:509-515
94. Ma B, Seymour JF, Januszewicz H, Slavin MA. Cure of pulmonary Rhizomucor pusillus infection in a patient with hairy-cell leukemia: role of liposomal amphotericin B and GM-CSF. Leuk Lymphoma 2001;42:1393-1399
95. Garcia-Diaz JB, Palau L, Pankey GA. Resolution of rhinocerebral zygomycosis associated with adjuvant administration of granulocyte-macrophage colony-stimulating factor. Clin Infect Dis 2001;32:e145-e150
96. Maury S, Leblanc T, Feuilhade M, Molina JM, Schaison G. Successful treatment of disseminated mucormycosis with liposomal amphotericin B and surgery in a child with leukemia. Clin Infect Dis 1998;26:200-202
97. Saltoglu N, Tasova Y, Zorludemir S, Dundar IH. Rhinocerebral zygomycosis treated with liposomal amphotericin B and surgery. Mycoses 1998;41:45-49